PharmaBoardroom

Alan Goh – CEO & Co-Founder, NDR Medical Technology

Alan Goh of NDR Medical Technology, a pioneer in intelligent navigation and image processing for minimally invasive surgery, introduces the progress…

Süha Taşpolatoğlu – CEO, Abdi Ibrahim

Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s ambitious bet on biosimilars, their…

Hatice Öncel – CEO, Ilko Pharmaceuticals

Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel explains the company’s investment in…

China Pharma Roundup: Sinopharm Tops Brand Value Rankings;…

The latest news from the Chinese pharmaceutical industry, including recent deals between domestic pharma giant Simcere and German biotech Vivoryon in…

João de Bragança & Nicole Scobie, Childhood Cancer…

Cancer is one of the most frightening words in any language but is especially heart-wrenching when it comes to children. João de Bragança, President…

China Enters CAR-T Era with Fosun-Kite Yescarta Approval

A historic approval for Fosun-Kite’s CAR-T therapy Yescarta in China looks set to pave the way for further developments in the Chinese cell and gene…

A New Era for Mental Health in Switzerland?

Mental health is a global crisis. 25 percent of the world’s population struggle with mental illness; and mental, neurological, and substance use…

US Generics & Biosimilars: Five Takeaways from Access! 2021

Dan Leonard of the Association for Accessible Medicines (AAM) highlights five key takeaways from the organisation’s remote but dynamic annual…

Aducanumab Approval: Opening the Floodgates for a New Era of…

With the US FDA’s controversial recent decision to approve Biogen and Eisai’s aducanumab – the first approval for a new Alzheimer’s disease…

Mohamed Nasser – General Manager, Amgen Middle East &…

Amgen’s Middle East and Africa General Manager Mohamed Nasser discusses the company’s approach to the region; the opportunities in the Saudi…

Philipp Haas – Chairman of BOD & CEO, DEVA

As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp…

If the “Primary Endpoint” in an Alzheimer’s…

Taking the example of music's effect on Alzheimer's disease patients, John G Singer makes the case for a more holistic approach to healthcare;…

Tagged with GEN